NY-METLIFE
MetLife, Inc. (NYSE: MET) today announced a number of changes to its senior leadership team. All changes are effective on January 1, 2021, unless otherwise noted.
Executive Vice President and President of the Latin America region Oscar Schmidt will retire after a distinguished 26-year career with the company. He will step away from his executive position on December 31, 2020, and will stay on through the end of March 2021 to assist with the leadership transition.
“Over the past two and a half decades, Oscar has helped us grow and develop our Latin America business, building a well-diversified portfolio of businesses across the region,” said MetLife President and CEO Michel Khalaf. “Under his strong leadership, we have grown to become the largest life insurer in Latin America – a distinction achieved organically and through a number of acquisitions.”
Succeeding Schmidt as Regional President, Latin America, will be Eric Clurfain , Executive Vice President and Chairman, President and CEO of MetLife Japan K.K., subject to the necessary approvals. He will report to Khalaf.
“With more than two decades of insurance experience, Eric has a proven track record of building high-performing teams and businesses and a deep commitment to our associates and customers,” Khalaf said. “Over the past two years, his intense focus on business execution and customer centricity has driven culture change in Japan and delivered strong results in support of our Next Horizon strategy. Under his leadership, I am confident LatAm will continue to be a growth engine for MetLife.”
Clurfain’s career path has spanned numerous geographies and strategic leadership responsibilities. Prior to his current role, Clurfain was Regional Head for EMEA with oversight over the region’s 25 markets. Previously, he was Regional Head for Central and Eastern Europe after serving as General Manager of MetLife in Turkey. Earlier in his career with AIG/Alico, Clurfain lived and worked in Latin America.
Succeeding Clurfain as Executive Vice President and Chairman, President and CEO of MetLife Japan K.K. will be Dirk Ostijn , Head of EMEA, subject to the necessary approvals. Ostijn will report to Executive Vice President Kishore Ponnavolu , Regional President, Asia.
“Dirk has successfully led our EMEA region through a challenging operating environment,” Khalaf said. “Under his leadership, the EMEA team built strong momentum with a robust pipeline of new business opportunities, a relentless focus on efficiency, and a diversified model spanning more than 25 markets. I know his exemplary leadership, deep insurance expertise, and passion for the customer will be welcomed and appreciated by our team in Japan.”
With more than 30 years of experience, Ostijn’s career encompasses all aspects of the life insurance industry, including product, finance, operations, customer service and technology. He also spent more than a decade managing insurance brokerage operations, served as a General Manager in Belgium and held regional roles such as chief financial officer and head of strategic initiatives.
Succeeding Ostijn as Head of EMEA will be Nuria Garcia , Senior Vice President and Deputy Head of EMEA. She will report to Khalaf.
“Nuria has a strong focus on business development and partnerships as well as a passion for the customer,” Khalaf said. “She is a highly effective leader who can connect internal and external stakeholders to collaborate across business, function and market. Her leadership played an integral role in the region’s continued strong performance, and I have every confidence that she will continue to build on this track record going forward.”
Garcia has more than 20 years of experience in EMEA spanning distribution, marketing, operations and finance, both with MetLife and GE.
“Taken together, these moves demonstrate not only our commitment to talent development and succession planning, but our deep bench of leaders who are ready to step up immediately and deliver value to our customers and shareholders,” Khalaf said.
About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com .
Forward-Looking Statements
The forward-looking statements in this disclosure, using words such as “will,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it has no obligation to correct or update any of these statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201015005425/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stafford Establishes Timberland Continuation Fund at USD 1.2 billion4.12.2025 10:53:00 CET | Press release
This marks Stafford’s second timberland fund at over USD 1 Billion in 2025, backed by strong existing investor support and new capital commitments from global institutional investors Stafford Capital Partners (“Stafford”) today announced it has established a USD 1.2 billion continuation vehicle, the Stafford International Timberland Continuation Fund (The Continuation Fund or The Fund), marking a significant milestone in the firm’s strategic management of its timberland holdings. The Continuation Fund is a "roll-up" of three of Stafford’s existing core timberland funds – Stafford International Timberland funds VI, VII and VIII – into a new perpetual fund that will hold 74 high-quality core timberland assets. The fully-deployed portfolio took Stafford seven years to construct and holds interests in over 6.3m acres of commercial timberland in the USA, New Zealand, Australia and Latin America. This includes a number of assets that are seen as key strategic holdings in these regions where
Smartstream Introduces Agentic AI ‘Smart Agents’ for Investigations and Exceptions Handling4.12.2025 09:55:00 CET | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces the preview of Smart Agents for Investigations, a breakthrough in financial operations that brings augmented and autonomous exception handling to reconciliations and back-office processes. The new investigation agent combines domain-trained AI agents, workflow adoption, and embedded controls to triage, investigate, resolve, and learn from exceptions - reducing manual effort, accelerating time to resolution, and strengthening auditability. It will add a layer of intelligence on top of Smartstream’s current reconciliations and exceptions solutions. It understands the breaks context, adheres to customer playbooks and reaches out for missing information. It documents every step for audit and compliance, allowing analysts to focus on risk. Finally, it augments the analyst’s investigation with contextual information radically changing the user experience to review and a
LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes4.12.2025 09:00:00 CET | Press release
The companies have entered into a new collaboration where LabGenius Therapeutics will apply its ML-driven antibody discovery platform (EVA™) to optimise potential therapeutic NANOBODY® proteins for multiple new targets LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic antibodies, today announced a second collaboration with Sanofi. This collaboration combines LabGenius’ AI/ML-driven antibody design capabilities with Sanofi’s expertise in the development of therapeutic NANOBODY® molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA™ platform to optimise NANOBODY® molecules for multiple new targets in the area of inflammation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204759388/en/ “We are truly excited abo
GoWit One: The Unified AI Operating System Set to Revolutionize Commerce & Retail Media4.12.2025 07:09:00 CET | Press release
WPP Turkey has been selected as a pilot partner to deploy GoWit One, cutting campaign setup time to 10 minutes. GoWit, a global AdTech leader in omnichannel Commerce and Retail Media, announced the launch of GoWit One, the unified AI operating system that brings automation, unification, and real-time intelligence into a single ad platform for agencies operating across multiple retailers, channels, and markets. By bringing these three elements into one dashboard, GoWit One addresses the industry's most critical bottleneck: operational inefficiency. The platform enables agencies to manage campaigns across multiple retailers, channels, and markets, reducing manual AdOps workflows by 98%, turning a process that used to take hours into as little as 10 minutes. Solving the “Fragmentation Crisis” Despite the explosive growth of Retail Media, the industry faces a significant hurdle. According to the IAB, 70% of the market still lacks end-to-end AI adoption. Media buyers are currently forced to
Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings4.12.2025 07:00:00 CET | Press release
‘BBB’ long-term issuer credit rating from S&P Global RatingsPositive outlook, reflecting expected profitability improvement, ramp up of Nemluvio, and continued deleveraging and balance sheet improvementRecognition of Galderma’s science-based dermatology portfolio and global operations Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned the company a ‘BBB’ long-term issuer credit rating with a positive outlook. The rating reflects Galderma’s strong track record of growth and its leading positions across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. S&P notes the company’s well-established brand portfolio, global footprint, including an expanding presence in emerging markets, and continued investment in science-based innovation. S&P highlights momentum from recent launches, including Nemluvio® (nemolizumab), alongside improving profitability and expanding free operating cash flow
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom